Physician profile
Kaitlyn Hammock
NPI 1053998377
$6,523.43
in general payments reported to CMS, 2019-2025
16 companies · $1,781 in 2025
The $1,781 reported for 2025 was more than what 81% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $4,743 · 2025: $1,781.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,782 · Travel and Lodging: $1,741.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,782.04 |
| Travel and Lodging | $1,741.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,937.64 | 2024-2025 | Ortholoc 3di, Ortholoc 2 Lapifuse, Augment Injectable |
| Paragon 28, INC. | $1,041.76 | 2024 | Bun-Yo-Matic, Portfolio |
| Arthrex, INC. | $1,016.14 | 2024-2025 | |
| Integra Lifesciences Corporation | $446.63 | 2024-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Aroa Biosurgery Incorporated | $239.49 | 2024 | |
| Paratek Pharmaceuticals, INC. | $227.59 | 2024-2025 | Nuzyra |
| Bone Support INC. | $138.37 | 2024 | Ceramentbone Void Filler, Cerament G |
| Orthofix Medical, INC. | $126.69 | 2025 | Truelok |
| Kerecis Limited | $107.20 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| W. L. Gore & Associates, INC. | $59.61 | 2024 | Gore Viabahn Endoprosthesis With Heparin |
| International Life Sciences | $47.31 | 2024 | Flexband |
| Averitas Pharma INC. | $37.15 | 2024 | Qutenza |
| Smith+Nephew, INC. | $34.25 | 2025 | Collagenase Santyl |
| Sanara Medtech INC. | $32.41 | 2024 | Celleraterx |
| Solventum Corporation | $16.73 | 2024 | Activ.A.C., Promogran Prisma, Kerramax Care |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mimedx Group, INC. | $14.46 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kaitlyn Hammock listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.